Drug Profile
Droxinavir
Alternative Names: SC 55389ALatest Information Update: 22 Dec 1995
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 22 Dec 1995 SC 55389A is now called droxinavir
- 06 Mar 1995 Discontinued-Preclinical for HIV infections treatment in USA (PO)